The Effect of Reduced Dose of Enoxaparin on the Outcomes of Treatment With Enoxaparin

• Conditions: Acute Coronary Syndrome; Venous Thromboembolism; Atrial Fibrillation; Hypercoagulability

• Registration Number: NCT00354796
• Lead Sponsor: Hadassah Medical Organization

Brief Summary

We hypothesize that reduced dose of enoxaparin in elderly patients will result in reduced proportion of patients with therapeutic anti Xa activity and reduced clinical efficacy.

Detailed Description

Patients treated with enoxaparin will be followed, sociodemographic , clinical and laboratory data will be collected. Clinical efficacy as well as adverse events will be monitored.

Study Timeline

• Study Start: 2006-07
• Study First Submitted: 2006-07-19
• Study First Submitted QC: 2006-07-19
• Study First Posted: 2006-07-20
• Status Verified: 2011-06
• Last Update Submitted: 2011-07-03
• Last Update Posted: 2011-07-06
• Study Completion: 2015-10

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 500

Inclusion Criteria

• treatment with enoxaparin

Exclusion Criteria

• no

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Trial Locations

Locations (1)

Hadassah Medical Organization; 🇮🇱 Jerusalem, Israel